Skip to main content
Screener/Healthcare/Biotechnology

ALKS — Alkermes plc

NASDAQ
$47.77+1.74 (+3.78%)
Mid CapUnder $50HealthcareFastest GrowingLow Beta
$25.16
$46.63
$45.47
$48.31
EPS (TTM)$0.90
P/E Ratio51.52
Dividend Yield—
Market Cap$7.42B
Volume1.42M
Prev Close$46.02
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$392.9M-$66.5M$-0.400.0%-16.9%
Q4 '25$384.5M$49.3M$0.2986.5%12.8%
Q3 '25$394.2M$82.8M$0.4986.9%21.0%
Q2 '25$390.7M$87.1M$0.5287.3%22.3%
Q1 '25$306.5M$22.5M$0.1383.9%7.3%
Q4 '24$430.0M$146.5M$0.8885.6%34.1%
Q3 '24$378.1M$92.4M$0.5583.3%24.4%
Q2 '24$399.1M$91.4M$0.5384.6%22.9%
Get Your Daily Market Recap